🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase III trial is studying APF530 and dexamethasone to see...
Status
Completed
Location
Anniston Oncology, PC
Start Date
2006-06
Trial ID
NCT00343460
Treatments Being Tested
This phase II trial studies the effect of ascorbic acid and combination che...
Status
Recruiting
Location
Mayo Clinic Health Systems-Mankato
Start Date
2018-03-23
Trial ID
NCT03418038
Treatments Being Tested
The purpose of this study is to determine if there is an improvement in pro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01266811
Treatments Being Tested
This study evaluates the potential synergic anti-myeloma activity of clarit...
Status
Terminated
Location
Department of Hematology, Aalborg University Hospital
Start Date
2015-01
Trial ID
NCT02573935
Treatments Being Tested
The purpose of this study is to compare the effects, good and/or bad, of a ...
Status
Unknown
Location
UAB Comprehensive Cancer Center
Start Date
2008-04
Trial ID
NCT00651261
Treatments Being Tested
This is a randomized controlled study of high-dose Dexamethasone combined w...
Status
Recruiting
Location
Qilu Hospital of Shandong University
Start Date
2026-04-08
Trial ID
NCT07559331
1. Scientific background In patients with multiple myeloma high-dose chemot...
Status
Unknown
Location
University Hospital of Heidelberg, Department V
Start Date
2005-07
Trial ID
NCT00571168
This is a phase III study designed to demonstrate the superiority of single...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2009-09
Trial ID
NCT00891761
Treatments Being Tested
The purpose of this study is to determine if subjects who receive Palonoset...
Status
Completed
Location
NYU Langone Medical Center
Start Date
2009-07
Trial ID
NCT00952133
Treatments Being Tested